Skip to content

The Study on Negative Cognitive Regulation and Dynamic Directed Brain Network of the Antidepressant Effect of Transcutaneous Electrical Cranial-Auricular Acupoints Stimulation

The Study on Negative Cognitive Regulation and Dynamic Directed Brain Network of the Antidepressant Effect of Transcutaneous Electrical Cranial-Auricular Acupoints Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001348
Enrollment
Unknown
Registered
2025-07-08
Start date
2025-07-08
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Interventions

Health Control Group:None
Control Group:Transcutaneous Cranio-Auricular Sham Stimulation
Experimental Group:Transcutaneous Cranio-Auricular Electrical Stimulation Treatment

Sponsors

Acupuncture and Rehabilitation Department of Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for mild to moderate depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders (5th Edition) (DSM-5); 2) Aged between 18 and 65 years; 3) HAMD-17 score between 7 and 20; 4) Absence of suicide risk: All responses on the Suicide Severity Rating Scale (SSRS) must be negative; Item 3 (Suicide) of HAMD-17 must have a score < 3; 5) No use of any psychotropic substances or acupuncture treatment within the past 1 month; 6) Willing to receive transcutaneous electrical stimulation of auricular acupoints; 7) Able to cooperate with resting-state and task-state EEG monitoring comprehend scale content comply with treatment and provide written informed consent for voluntary participation.

Exclusion criteria

Exclusion criteria: 1) Comorbid severe somatic diseases such as coronary heart disease malignant tumors renal failure etc.; 2) Comorbid organic brain disorders; 3) Comorbid other psychiatric disorders personality disorders or substance abuse/dependence; 4) Inability to complete washout period for sleep-aid medications or acupuncture therapy; 5) Pregnant or lactating women; 6) Severe skin lesions in the auricular region; 7) Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Secondary

MeasureTime frame
Task-state EEG;PSQI;Resting-state EEG;APNI;Negative Cognitive Processing Bias Questionnaire;?-GABA Level;HAMA-14;Cortisol Level;5-HT Level;Chinese Medicine Constitution Classification and Judgment Self-Test Table;Resting-state ECG;

Countries

China

Contacts

Public ContactChengyong Liu

Jiangsu Province Hospital of Chinese Medicine

lcy8601@163.com+86 13851415038

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026